Company intelligence / Profile preview
Genericon Pharma
- Ownership
- Private
- Development stage
- Commercial
Overview
Genericon Pharma is a well-established Austrian pharmaceutical company specializing in high-quality generics. They distribute around 19 million pharmaceutical packs annually in Austria together with their subsidiary +pharma arzneimittel gmbh[4].
- Therapeutic areas
- Men's HealthMetabolic DisordersPsychiatryGastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Genericsnutritional supplements
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Genericon Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genericon Pharma.